King Pharmaceuticals KG Commercial Auto Liability — Year 2
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's commercial auto liability — year 2.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's commercial auto liability — year 2?
- King Pharmaceuticals (KG) reported commercial auto liability — year 2 of 17.6% in Q4 2025.
- What does commercial auto liability — year 2 mean?
- This metric tracks the loss development or financial performance data for the commercial auto liability segment during the second year of the policy cycle. It provides insight into the maturation of claims and the accuracy of initial reserve estimates. It is a key component of the loss development triangle analysis.